These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25661865)

  • 1. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
    Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
    Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control.
    Lee SM; Kim M; Lee HM; Kwon KY; Koh SB
    J Neurol Sci; 2015 Feb; 349(1-2):168-73. PubMed ID: 25641389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
    Shi X; Zheng J; Ma J; Wang Z; Sun W; Li M; Huang S; Hu S
    Neurosci Lett; 2022 Jul; 783():136735. PubMed ID: 35709879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson's disease patients.
    Shi X; Zheng J; Ma J; Li D; Gu Q; Chen S; Wang Z; Sun W; Li M
    Neurol Sci; 2023 Mar; 44(3):881-887. PubMed ID: 36383265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between rate of nonmotor symptom development in essential tremor and Parkinson's disease.
    Sengul Y; Sengul HS; Sural MK; Bakim B; Forta H
    Acta Neurol Belg; 2015 Sep; 115(3):289-94. PubMed ID: 25527389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease.
    Pellecchia MT; Santangelo G; Picillo M; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; De Rosa A; Moccia M; Erro R; De Michele G; Santoro L; Colao A; Barone P
    Eur J Neurol; 2014 May; 21(5):802-7. PubMed ID: 23551560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease.
    Godau J; Herfurth M; Kattner B; Gasser T; Berg D
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):536-8. PubMed ID: 20176597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.
    Picillo M; Pivonello R; Santangelo G; Pivonello C; Savastano R; Auriemma R; Amboni M; Scannapieco S; Pierro A; Colao A; Barone P; Pellecchia MT
    PLoS One; 2017; 12(10):e0186508. PubMed ID: 29065116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases of pentraxin 3 plasma levels in patients with Parkinson's disease.
    Lee HW; Choi J; Suk K
    Mov Disord; 2011 Nov; 26(13):2364-70. PubMed ID: 21953577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.
    Sánchez-Ferro Á; Benito-León J; Louis ED; Contador I; Hernández-Gallego J; Puertas-Martín V; Bermejo-Pareja F
    Acta Neurol Scand; 2017 Nov; 136(5):393-400. PubMed ID: 28261780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pattern of cognitive-functional decline in elderly essential tremor patients: an exploratory-comparative study with Parkinson's and Alzheimer's disease patients.
    Frisina PG; Tse W; Hälbig TD; Libow LS
    J Am Med Dir Assoc; 2009 May; 10(4):238-42. PubMed ID: 19426939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia].
    Niccoli Asabella A; Ruggeri M; Rubini D; Polimeno L; Spinelli C; Polito M; Pennelli M; Altini C; De Caro MS; Defazio G; Rubini G
    Recenti Prog Med; 2013; 104(7-8):393-7. PubMed ID: 24042414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease.
    Rocha NP; Teixeira AL; Scalzo PL; Barbosa IG; de Sousa MS; Morato IB; Vieira EL; Christo PP; Palotás A; Reis HJ
    Mov Disord; 2014 Apr; 29(4):527-31. PubMed ID: 24301904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.
    Vidal JS; Hanon O; Funalot B; Brunel N; Viollet C; Rigaud AS; Seux ML; le-Bouc Y; Epelbaum J; Duron E
    J Alzheimers Dis; 2016 Mar; 52(2):641-9. PubMed ID: 27031487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid status and cognitive function in euthyroid patients with early Parkinson's disease.
    Choi SM; Kim BC; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Kim MK; Cho KH
    Dement Geriatr Cogn Disord; 2014; 38(3-4):178-85. PubMed ID: 24732425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
    Bernhard FP; Heinzel S; Binder G; Weber K; Apel A; Roeben B; Deuschle C; Maechtel M; Heger T; Nussbaum S; Gasser T; Maetzler W; Berg D
    PLoS One; 2016; 11(3):e0150552. PubMed ID: 26967642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease.
    Mashayekhi F; Mirzajani E; Naji M; Azari M
    J Clin Neurosci; 2010 May; 17(5):623-7. PubMed ID: 20189394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher serum insulin-like growth factor-1 is associated with better cognitive performance in persons with mild cognitive impairment.
    Calvo D; Gunstad J; Miller LA; Glickman E; Spitznagel MB
    Psychogeriatrics; 2013 Sep; 13(3):170-4. PubMed ID: 25913765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.